Leverage our omni-channel approach to grow your brand across Asia Pacific.
We seek to advance highly specialised and scientifically valuable fields to elevate the standard of healthcare.
Discover more about Menarini Group
For over 30 years, Menarini has been driving research and development to deliver innovative and effective medicines and healthcare solutions for patients affected by serious health conditions.
Gain a single point of entry to all major APAC markets with a direct presence in 13 key markets.
Sharing your partnering idea
Leverage our omni-channel approach to grow your brand across Asia Pacific.
Global Responsibility
FOLLOW US
Global Press Releases
FOLLOW US
MARKETS
The healthcare sector in Asia Pacific is rapidly growing. As part of the world’s leading Italian biopharmaceutical company, Menarini AP has a strong presence in 13 key markets across the region.
As a partner of choice for numerous global healthcare companies, we engage in the entire pharmaceutical development lifecycle to tap growth opportunities and grow their brand footprint. In doing so, we also support healthcare professionals and patients with quality medical products and technology to raise standards and invigorate lives for tomorrow.
Our APAC Headquarters
A. MENARINI ASIA-PACIFIC HOLDINGS PTE LTD
A. MENARINI ASIA-PACIFIC PRIVATE LIMITED
A. MENARINI SINGAPORE PTE LTD
A. MENARINI BIOMARKERS SINGAPORE PTE LTD
30 Pasir Panjang Road,
Mapletree Business City,
#08-32 Singapore 117440
Tel: +65-6494-7200
Fax: +65-6999-1787
Who We Are
Since our inception on 12 July 1973, Menarini Indonesia been enlarging its business footprint to meet growing demand for quality medical solutions. From product development, regulatory approval and product launches to lifecycle management, Menarini Indonesia’s team of over 340 employees oversees a vibrant portfolio of proprietary and partnered brands in key therapeutic fields. Emphasising Consumer Health, Dermatology, Allergy/Respiratory, Cardiovascular, Primary Care, Pain, Oncology and Specialty Care, we partner some of the world’s leading pharmaceutical companies in advancing their brands throughout the archipelago.
Supporting this drive is our joint-venture manufacturing plant, PT Menarini Indria Laboratories (Milabs). Specialising in the production of drugs and medical devices, the facility houses a Distribution Centre, a Medical Device facility, tablet manufacturing capabilities and a Regional Distribution Hub. The award-winning plant holds the following licenses and certificates:
• Drug (Modern) GMP
• GMP Certificates: tablet, oral liquid, semisolid
• Joint Facility Cosmetics Semisolid
• Medical Device License
• ISO 13485 certified
• Halal certification
Therapeutic Areas
In building strategic partnerships, we tap our deep expertise to offer our partners tailor-made solutions as well as access to key markets across Asia Pacific. At the same time, our dynamic omnichannel capabilities present multiple opportunities and avenues to expand our reach and realise the full potential of our portfolio. Members of the public are advised to consult a healthcare professional before commencing use of any of our products.
Dermatology
Allergy/Respiratory
Cardiovascular
Primary Care
Pain
Oncology
Speciality Care
At Menarini Indonesia, we continually enhance our strengths and build new capabilities to advance our mission of Invigorating Lives. As we drive execution excellence across the commercial team, we also shape a winning product portfolio to deliver high value in both the short and long term. With Milabs, we adopt a future-focused site strategy anchored in greater productivity.
Throughout our organisation, we implement key initiatives for all Menarinians to live out our DNA values every day, while strengthening our reputation as the Partner of Choice among all our stakeholders.
Idham Hamzah
General Manager
CSR
We have identified the following pillars under the UN Sustainable Development Goals (UN SDG). Together, these reflect our community’s most urgent needs and anchor our drive for greater sustainability.
Contact Us
PT Transfarma Medica Indah
Unit 802, 8th Fl. Pondok Indah
Office Tower 2, Jl. Sultan Iskandar
Muda Kav V-TA, Pondok Indah,
Kebayoran Lama, Jakarta Selatan,
DKI Jakarta Raya 12310, Indonesia
Tel: +62-21-7697323
Fax: +62-21-769-7150,
+62-21-7697528
Business Development:
idn_bd@menariniapac.com
PT Menarini Indria Laboratories
Jl. Akasia II Blok A9 No.5,
Delta Silicon 1, Industrial Park,
Sukaresmi Cikarang Selatan,
Lippo Cikarang, Bekasi,
Jawa Barat 17550, Indonesia
Tel: +62-21-8972817
Fax: +62-21-897-2816
Email:
hardi.wibowo@menariniapac.com
Explore Our APAC Markets
We Invigorate Lives in key markets across Asia Pacific.
Adverse Event Reporting
If you wish to report an adverse event relating to a Menarini product, please contact us at
Phone & WhatsApp: +62-811-9650-9581;or
Medical Information Enquiries
For medical information or product quality enquiries about Menarini therapies (Medical Devices) purchased in Indonesia, please
Drugs, Cosmetics, Quasi Drugs
For medical information or product quality enquiries about Menarini therapies (Drugs, Cosmetics, Traditional Medicine, Quasi Drug) purchased in Indonesia, please